Targeting USP47 enhances the efficacy of KRAS inhibitor in KRASG12C mutated non-small cell lung cancer by controlling deubiquitination of c-Myc

Targeted Therapy
DOI: 10.1016/j.phrs.2025.107722 Publication Date: 2025-04-04T14:36:53Z